My Treatment Approach: Optimizing Treatment for Chronic GVHD - Episode 9

Recent Updates: REACH3, ROCKstar, and RWD

,

Medical experts discuss the recent updates presented at ASH 2023 and TANDEM 2024.

Video content above is prompted by the following:

  1. Briefly discuss recent updates presented at ASH 2023 and TANDEM 2024:
  • 3-year analysis of REACH3, ASH 2023
  • 3-year follow-up of the ROCKstar study, TANDEM 2024
  1. Brie fly discuss available real-world data (RWD) with ruxolitinib (Spałek A, et al. Pol Arch Intern Med. 2023) and ibrutinib (Chin KK, et al. Transplant Cell Ther. 2021;White J, et al. Transplant Cell Ther. 2023).